nejm semaglutide heart failure Despite the long-time use of cardiac glycosides in the treatment of failure, evidence of their potential benefit in patients with heart and reduced ejection fraction is limited. In a decades-old Semaglutide and cardiovascular outcomes in

Wang S, Wen J, Wang Z, Meng H

Although Eli Lilly has not yet submitted the drug for approval to the Food and Drug Administration, the company stated that it plans to file for approval later this year

This piece explains how to convert dosages between milligrams and unitsa key difference between brands like Ozempic and Wegovy

To help with that, MeAgain's GLP-1 app offers simple dose reminders, symptom tracking for dizziness or lightheadedness, hydration logs, and quick, actionable tips to help you spot patterns and share precise data with your clinician

Results are expressed as estimated mean or estimated mean difference from T0 with their 95% confidence interval (95% CI)

The rate of GLP-1 receptor agonist use rose more than threefold during the study period, from 8.6% in 2018 to 26.8% in 2023, the researchers found